AG
PRVL

Artal Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Artal Group’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-302,750
Closed -$3.08M – 157
2020
Q3 		$3.08M Sell
302,750
-67,250
-18% -$685K 0.07% 101
2020
Q2 		$5.51M Buy
370,000
+170,000
+85% +$2.53M 0.15% 85
2020
Q1 		$2.44M Buy
+200,000
New +$2.44M 0.1% 84